Song-Ze DING Ph.D
Department of Gastroenterology & Center for Translational Medicine Henan Provincial People’s Hospital, Zhengzhou University · China
Editorial leadership for Journal of Ulcers
Research interests
- H. Pylori Infection
- Oncogenic Transformation
- Stem Cell
- Epithelial Cancer; Identification
- Screening Of Serum Biomarkers For Gastrointestinal Cancers
Biography
<div dir="ltr" style="box-sizing: border-box; font-size: 12pt; line-height: 1.5rem; color: rgb(0, 0, 0); letter-spacing: 0.15px; font-family: Calibri, Helvetica, sans-serif, EmojiFont, " apple="" color="" emoji",="" "segoe="" ui="" notocoloremoji,="" symbol",="" "android="" emojisymbols;"="">
Dr. Song-Ze Ding is a Professor of Gastroenterology and Hepatology at People's Hospital of Zhengzhou University, or Henan Provincial People's Hospital, in Zhengzhou, Henan, China. He received his MD/Ph.D. from Beijing Medical University in 1992, and firstly served as clinical physician in Gastroenterology and Hepatology, and later pursued postdoctoral work at University of Texas and University of Virginia in Helicobacter pylori infection related gastric disease research. Dr. Ding also served as an Associate Professor in the Institute for Genetic Medicine at Hokkaido University, in Sapporo, Japan. His research is focused on inflammation, stem cell, epigenetics and epithelial cancer. The primary model is Helicobacter pylori infection related human gastric diseases. He is currently editorial board member for eight international journals, also serves as expert reviewer for more than 30 reputed international journals, and has more than 30 publications in peer-reviewed international journals.
Selected publications
- Chinese Consensus Report on Family-Based Helicobacter pylori Infection Control and Management (2021 Edition) 2021 cited 158×
- Large-scale, national, family-based epidemiological study on Helicobacter pylori infection in China: the time to change practice for related disease prevention 2023 cited 140×
- Whole family—based Helicobacter pylori eradication is a superior strategy to single‐infected patient treatment approach: A systematic review and meta‐analysis 2021 cited 33×
- Rabeprazole plus amoxicillin dual therapy is equally effective to bismuth‐containing quadruple therapy for Helicobacter pylori eradication in central China: A single‐center, prospective, open‐label, randomized‐controlled trial 2022 cited 25×
- Both family‐based Helicobacter pylori infection control and management strategy and screen‐and‐treat strategy are cost‐effective for gastric cancer prevention 2022 cited 21×
- Global Prevalence of Helicobacter pylori Infection‐Associated Gastric Preneoplastic Lesions in Pediatric Patients: A Systematic Review and Meta‐Analysis Recent 2025 cited 10×
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering JU for your work?
This journal is guided by Song-Ze DING (Department of Gastroenterology & Center for Translational Medicine Henan Provincial People’s Hospital, Zhengzhou University) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.